Cited 18 times in
A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.